分享到
SHVRI Researchers Identify a Novel Mechanism for Immune Enhancement of Nano-adjuvant
Recently, Dr. Meng Chunchun from Shanghai Veterinary Research Institute (SHVRI) of Chinese Academy of Agricultural Sciences (CAAS) and Dr. Zhi Xiao from the Institute of Nano Biomedicine and Engineering of Shanghai Jiao Tong University explored a novel immune enhancement mechanism of Graphene Oxides with mice model. This finding has been published in the ACS nano and availableat: http://pubs.acs.org/doi/10.1021/acsnano.5b06750.
They decorated ultra-small graphene oxide with an antioxidant carnosine as a new immune adjuvant. Then prepared OVA@GO-Car using simply mixing ovalbumin (OVA, a model antigen) with ultra-small GO covalently modified with carnosine (GO-Car). Furthermore they investigated the immunological properties of the GO-Car in model mice in comparison with Go. Results show that OVA@GO-Car can promote robust and durable OVA specific antibody response, increase lymphocyte proliferation efficiency and enhance CD4+ T and CD8+ T cells activation. The presence of Car in GO also probably contributes to enhancing the antigen-specific adaptive immune response through modulating the innate immune level. In addition, the safety of GO-Car as an adjuvant was evaluated comprehensively. Besides, no toxic and side effect were observed. The study suggests that GO-Car as a new and safe adjuvant can effectively enhance humoral and innate immune responses against antigens in vivo.
By Meng Chunchun
mengcc@shvri.ac.cn
They decorated ultra-small graphene oxide with an antioxidant carnosine as a new immune adjuvant. Then prepared OVA@GO-Car using simply mixing ovalbumin (OVA, a model antigen) with ultra-small GO covalently modified with carnosine (GO-Car). Furthermore they investigated the immunological properties of the GO-Car in model mice in comparison with Go. Results show that OVA@GO-Car can promote robust and durable OVA specific antibody response, increase lymphocyte proliferation efficiency and enhance CD4+ T and CD8+ T cells activation. The presence of Car in GO also probably contributes to enhancing the antigen-specific adaptive immune response through modulating the innate immune level. In addition, the safety of GO-Car as an adjuvant was evaluated comprehensively. Besides, no toxic and side effect were observed. The study suggests that GO-Car as a new and safe adjuvant can effectively enhance humoral and innate immune responses against antigens in vivo.

By Meng Chunchun
mengcc@shvri.ac.cn
Latest News
-
Apr 18, 2024Opening Ceremony of the Training Workshop on Wheat Head Scab Resistance Breeding and Pest Control in Africa Held in CAAS
-
Apr 03, 2024IPPCAAS Co-organized the Training Workshop on Management and Application of Biopesticides in Nepal
-
Mar 28, 2024Delegation from the School of Agriculture and Food Science of University College Dublin, Ireland Visit to IAS, CAAS
-
Mar 25, 2024Director of World Food Prize Foundation visited GSCAAS
-
Mar 20, 2024Institute of Crop Sciences (ICS) and Syngenta Group Global Seeds Advance Collaborative Research in the Seed Industry